AGIOS PHARMACEUTICALS INC's ticker is AGIO and the CUSIP is 00847X104. A total of 159 filers reported holding AGIOS PHARMACEUTICALS INC in Q1 2017. The put-call ratio across all filers is 0.95 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $593,520 | -12.7% | 24,000 | 0.0% | 0.20% | -3.4% |
| Q2 2023 | $679,680 | -96.8% | 24,000 | +4942.0% | 0.21% | -7.6% |
| Q2 2022 | $21,500,000 | +2941.0% | 476 | -97.8% | 0.22% | +40.9% |
| Q1 2022 | $707,000 | 0.0% | 21,500 | 0.0% | 0.16% | +0.6% |
| Q4 2021 | $707,000 | -28.7% | 21,500 | 0.0% | 0.16% | -33.9% |
| Q3 2021 | $992,000 | -16.3% | 21,500 | 0.0% | 0.24% | -23.6% |
| Q2 2021 | $1,185,000 | +6.9% | 21,500 | 0.0% | 0.31% | +6.8% |
| Q1 2021 | $1,108,000 | +18.9% | 21,500 | 0.0% | 0.29% | +14.9% |
| Q4 2020 | $932,000 | +23.9% | 21,500 | 0.0% | 0.26% | +4.9% |
| Q3 2020 | $752,000 | -34.0% | 21,500 | 0.0% | 0.24% | -35.9% |
| Q2 2020 | $1,139,000 | +49.5% | 21,500 | 0.0% | 0.38% | +9.2% |
| Q1 2020 | $762,000 | -56.3% | 21,500 | -41.1% | 0.35% | -44.7% |
| Q4 2019 | $1,743,000 | +47.7% | 36,500 | 0.0% | 0.63% | +15.2% |
| Q3 2019 | $1,180,000 | -35.2% | 36,500 | 0.0% | 0.54% | -19.3% |
| Q2 2019 | $1,821,000 | -26.0% | 36,500 | 0.0% | 0.68% | -25.8% |
| Q1 2019 | $2,462,000 | +86.4% | 36,500 | 0.0% | 0.91% | +11.0% |
| Q4 2018 | $1,321,000 | -38.8% | 36,500 | 0.0% | 0.82% | -20.1% |
| Q3 2018 | $2,159,000 | -29.8% | 36,500 | 0.0% | 1.03% | -13.1% |
| Q2 2018 | $3,074,000 | +3.0% | 36,500 | 0.0% | 1.18% | +1.4% |
| Q1 2018 | $2,985,000 | +161.2% | 36,500 | +82.5% | 1.16% | +188.8% |
| Q4 2017 | $1,143,000 | -14.3% | 20,000 | 0.0% | 0.40% | -22.4% |
| Q3 2017 | $1,334,000 | -29.9% | 20,000 | -45.9% | 0.52% | -28.3% |
| Q2 2017 | $1,904,000 | +63.0% | 37,000 | +85.0% | 0.72% | +62.0% |
| Q1 2017 | $1,168,000 | – | 20,000 | – | 0.45% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Flagship Ventures 2007 General Partner LLC | 1,930,369 | $118,428,000 | 83.56% |
| Third Rock Ventures, LLC | 3,070,090 | $188,350,000 | 21.97% |
| Opaleye Management Inc. | 113,500 | $6,963,225,000 | 5.43% |
| BB BIOTECH AG | 1,890,521 | $115,983,000 | 4.72% |
| Eventide Asset Management | 431,600 | $26,479,000 | 3.70% |
| Atika Capital Management LLC | 54,000 | $3,313,000 | 2.55% |
| Cormorant Asset Management, LP | 100,000 | $6,135,000 | 1.26% |
| BRIDGER MANAGEMENT, LLC | 220,099 | $13,503,000 | 0.92% |
| Ghost Tree Capital, LLC | 20,000 | $1,227,000 | 0.67% |
| HAMILTON LANE ADVISORS LLC | 27,544 | $1,690,000 | 0.55% |